Evidence map›Paper›PMID 25372388›Full record

ArticlePloS one2014

Caspase-3 mediates the pathogenic effect of Yersinia pestis YopM in liver of C57BL/6 mice and contributes to YopM's function in spleen.

Zhan Ye, Amanda A Gorman, Annette M Uittenbogaard, Tanya Myers-Morales, Alan M Kaplan, Donald A Cohen, Susan C Straley

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Current Challenges inMicroorganisms · 2025
    Review
  2. Review
  3. Article
  4. AllFrontiers in cellular and infection microbiology · 2018
    Review
  5. Review
  6. Article
  7. Yersinia type III effectors perturb host innate immune responses.World journal of biological chemistry · 2016
    Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhan YeDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington, KY, United States of America.
Amanda A GormanDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington, KY, United States of America.
Annette M UittenbogaardDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington, KY, United States of America.
Tanya Myers-MoralesDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington, KY, United States of America.
Alan M KaplanDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington, KY, United States of America.
Donald A CohenDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington, KY, United States of America.
Susan C StraleyDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington, KY, United States of America.
University of Kentucky · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
YopM and protective innate defenses against plagueR01AI067869 · NIAID · UNIVERSITY OF KENTUCKY · PI STRALEY, SUSAN C · 2007 to 2011
$2.2M
Cell Sorter Upgrade for Flow Cytometry Service FacilityS10RR026827 · NCRR · UNIVERSITY OF KENTUCKY · PI COHEN, DONALD A · 2011 to 2011
$600k
NCI NIH HHS P30 CA177558NCRR NIH HHS S10 RR026827NCRR NIH HHS S10 RR026827-01A1NIAID NIH HHS R01 AI067869
6 · The paper itself

Abstract

The virulence protein YopM of the plague bacterium Yersinia pestis has different dominant effects in liver and spleen. Previous studies focused on spleen, where YopM inhibits accumulation of inflammatory dendritic cells. In the present study we focused on liver, where PMN function may be directly undermined by YopM without changes in inflammatory cell numbers in the initial days of infection, and foci of inflammation are easily identified. Mice were infected with parent and ΔyopM-1 Y. pestis KIM5, and effects of YopM were assessed by immunohistochemistry and determinations of bacterial viable numbers in organs. The bacteria were found associated with myeloid cells in foci of inflammation and in liver sinusoids. A new in-vivo phenotype of YopM was revealed: death of inflammatory cells, evidenced by TUNEL staining beginning at d 1 of infection. Based on distributions of Ly6G(+), F4/80(+), and iNOS(+) cells within foci, the cells that were killed could have included both PMNs and macrophages. By 2 d post-infection, YopM had no effect on distribution of these cells, but by 3 d cellular decomposition had outstripped acute inflammation in foci due to parent Y. pestis, while foci due to the ΔyopM-1 strain still contained many inflammatory cells. The destruction depended on the presence of both PMNs in the mice and YopM in the bacteria. In mice that lacked the apoptosis mediator caspase-3 the infection dynamics were novel: the parent Y. pestis was limited in growth comparably to the ΔyopM-1 strain in liver, and in spleen a partial growth limitation for parent Y. pestis was seen. This result identified caspase-3 as a co-factor or effector in YopM's action and supports the hypothesis that in liver YopM's main pathogenic effect is mediated by caspase-3 to cause apoptosis of PMNs.

Indexed as

Yersinia pestisAnimalsBacterial Outer Membrane ProteinsCaspase 3Cell DeathDisease Models, AnimalFemaleHost-Pathogen InteractionsInflammationLiverMiceMice, Inbred C57BLMice, KnockoutNeutrophilsNitric Oxide Synthase Type IIPlagueBacterial Outer Membrane ProteinsCaspase 3Nitric Oxide Synthase Type IIVirulence FactorsyopM protein, Yersinia

Identifiers

PMID25372388
PMCPMC4220956
OpenAlexW2004544031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.